Literature DB >> 1698324

In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.

R Mahalingam1, G Cabirac, M Wellish, D Gilden, A Vafai.   

Abstract

The varicella zoster virus (VZV) and herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) genes were cloned into the transcription vector pGEM4. In-vitro translation (ivt) of RNA transcribed from these genes showed prominent expression of functional TK proteins with the expected molecular weights of 36 kD for VZV and 43, 39, and 38 kD for HSV-1. The TK proteins were recognized by rabbit anti-VZV and anti-HSV-1 antibodies, respectively. Analysis of the ivt products by thin-layer chromatography revealed the conversion of thymidine to its phosphorylated forms (TMP, TDP, and TTP) by both the VZV and HSV-1 TK genes. The estimated specific activities of the in-vitro translated VZV and HSV-1 TKs were comparable. VZV TK templates were linearized at internal restriction sites and RNAs transcribed from these templates directed the synthesis of polypeptides with sizes consistent with the colinearity of the VZV TK gene. Deletion of 107 amino acids at the carboxy terminus of the VZV TK gene abolished the in-vitro TK activity. In addition, immunoprecipitation of truncated proteins synthesized in vitro suggested the possible involvement of the region between amino acid residues 101 and 168 from the amino terminus of the VZV TK molecule in the formation of structures necessary for antigenicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698324     DOI: 10.1007/bf00678403

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  40 in total

1.  Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion.

Authors:  R B Tenser; M E Dunstan
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

2.  Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide.

Authors:  D Graham; B A Larder; M M Inglis
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

3.  Translational regulation of SV40 early mRNA defines a new viral protein.

Authors:  K Khalili; J Brady; G Khoury
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells.

Authors:  T Hackstadt; L P Mallavia
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

Review 5.  Thymidine kinase.

Authors:  S Kit
Journal:  Microbiol Sci       Date:  1985-12

6.  Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons.

Authors:  H S Marsden; L Haarr; C M Preston
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

7.  Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activity.

Authors:  D I Dorsky; C S Crumpacker
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus.

Authors:  H Mori; K Shiraki; T Kato; Y Hayakawa; K Yamanishi; M Takahashi
Journal:  Intervirology       Date:  1988       Impact factor: 1.763

9.  Utilization of internal AUG codons for initiation of protein synthesis directed by mRNAs from normal and mutant genes encoding herpes simplex virus-specified thymidine kinase.

Authors:  L Haarr; H S Marsden; C M Preston; J R Smiley; W C Summers; W P Summers
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  3 in total

1.  Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.

Authors:  T Suzutani; M Saijo; M Nagamine; M Ogasawara; M Azuma
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal Ganglia.

Authors:  Randall J Cohrs; James J Laguardia; Donald Gilden
Journal:  Virus Genes       Date:  2005-10       Impact factor: 2.332

3.  Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.

Authors:  G B Roberts; J A Fyfe; R K Gaillard; S A Short
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.